# Opada Alzohaili, M.D. – FDA Inspection, Mar 29, 2016

Source: https://www.keypedia.com/records/fda_inspections/opada-alzohaili-md/442ea114-bc35-4c69-a4e5-35f83880fc0d
Source feed: FDA_Inspections

> FDA inspection 968166 of Opada Alzohaili, M.D., March 29, 2016. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 50 and 312. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 968166
- Company Name: Opada Alzohaili, M.D.
- Inspection Date: 2016-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 968583 - 2016-03-29](https://www.keypedia.com/records/fda_inspections/opada-alzohaili-md/15a25c00-f3be-467d-93f2-e5efa681b613)
- [FDA Inspection 844221 - 2013-08-14](https://www.keypedia.com/records/fda_inspections/opada-alzohaili-md/c51f2367-443b-48c1-8d05-7450bda1a4ff)

Company: https://www.keypedia.com/companies/opada-alzohaili-md/d50daa52-079f-4319-af28-d2f3442df575

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c